Voyageur Pharmaceuticals Ltd.

VYYRF

HealthcareOTCCA

$0.014

$0.00 (+0.00%)

VYYRF

Analysis Workspace

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.

Consensus

N/A

Quality

N/A

Price Target

N/A

Forward Revenue

$1.40M

Nov 2024

Voyageur Pharmaceuticals Ltd. · Forecast overview

Model view

Forward Revenue

$1.40M

Nov 2024

Revenue range

Low: $1.40M

High: $1.40M · Annual

EPS avg

-$0.10

Consensus

Analyst coverage

Analysts

Bars show expected revenue while the line tracks expected EPS.

Annual

1 periods

Period	Revenue avg	Revenue range	EBITDA	EPS avg	Analysts
Nov 2024	$1.40M	$1.40M - $1.40M	$838.3K	-$0.10	1

Loading analysis workspace